首页> 中文期刊> 《临床与病理杂志》 >Application of Mir-301a in the prediction of chemosensitivity and evaluation of the effect of neoadjuvant chemotherapy in gastric cancer

Application of Mir-301a in the prediction of chemosensitivity and evaluation of the effect of neoadjuvant chemotherapy in gastric cancer

         

摘要

Objective:Previous research has revealed an elevated expression of miR-301a in gastric cancer. Our study aimed to explore the potential role of miR-301a as a biomarker for predicting the chemosensitivity and evaluating the effect of NAC in gastric cancer.Methods: hTe expression levels of circulating miR-301a in plasma of 50 patients with advanced gastric cancer were assessed before and atfer NAC, as well as in 50 healthy individuals. hTe correlations between miR-301a and clinicopathological features, traditional measures like CT, EUS and tumor markers were also analysed. Results:MiR-301a showed a higher expression in patients’ plasma than healthy individuals (P=0.01). The expression was signiifcantly associated with NAC sensitivity (P=0.006) and tumor downstaging (P=0.002). After NAC, significant decreased miR-301a levels are often accompanied by preferable tumor remission, showing a better NAC sensitivity. Meanwhile, the traditional measures (CT, EUS, tumor markers) showed much less accuracy comparing with miR-301a.Conclusion:Our results indicate that plasma miR-301a may be a potential biomarker for evaluating the effect of NAC and predicting chemoresistance in gastric cancer.

著录项

  • 来源
    《临床与病理杂志》 |2015年第z1期|55-56|共2页
  • 作者

  • 作者单位
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号